<DOC>
	<DOCNO>NCT01920737</DOCNO>
	<brief_summary>The purpose study find whether combination chemotherapy drug routinely use child ALL , safe effective treat adult patient ALL . The standard treatment adult ALL consist many chemotherapy drug give different combination several step . In adult ALL standard drug give combine . Some leukemias chromosome abnormality call Philadelphia chromosome ( also call Ph Positive ) leukemia ( call Ph Negative ) . In study want see whether combination chemotherapy drug safe effective treat adult patient Ph Negative ALL .</brief_summary>
	<brief_title>A Novel `` Pediatric-Inspired '' Regimen With Reduced Myelosuppressive Drugs Adults ( Aged 18-60 ) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Pegaspargase</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Daunorubicin</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<mesh_term>6-Mercaptopurine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Previously untreated Ph negative precursor Bcell Tcell ALL confirm conventional flow cytometry immunohistochemical stain Patients untreated Bcell Tcell ALL confirm conventional flow cytometry immunohistochemical stain , Ph status unknown , may also enroll . Patients Tcell B cell lymphoblastic lymphoma confirm conventional immature T pre B cell marker even bone marrow involve also eligible Age 18 60 year ECOG performance status 02 Adequate renal function demonstrate serum creatinine ≤ 2.0 mg/dl creatinine clearance &gt; 60 ml/min . Adequate hepatic function demonstrate total bilirubin &lt; 2.0 mg/dl ( unless attributable Gilbert 's disease ) alkaline phosphatase , AST , ALT ≤ 4 time upper limit normal ( unless clinically consider related liver involvement leukemia Normal cardiac function demonstrate leave ventricular ejection fraction ≥ 50 % echocardiogram MUGA scan Negative serum pregnancy test woman childbearing potential Men woman childbearing potential must willing practice effective method birth control treatment least 4 month treatment finish . Patients central nervous system involvement ALL eligible may receive concomitant treatment radiation therapy and/or intrathecal chemotherapy accordance standard medical practice . For patient CNS disease , dexamethasone may temporarily administer instead prednisone reduce CNS pressure , discretion treat physician discussion MSK PI . Once dexamethasone longer need , prednisone give per protocol 28 day . Previous treatment ALL , except prior steroid and/or hydroxyurea Patients know Philadelphia ( Ph ) + ALL eligible . Leukemia cell sample obtain patient enrol start protocol treatment submit Philadelphia chromosome test either karyotyping , bcr/abl1 translocation FISH PCR bcr/abl1 . Patients later find Ph+ ALL treatment trial discontinue consider evaluation Lymphoid blastic crisis chronic myelogenous leukemia Mature Bcell ( Burkitt 's ) ALL Active serious infection control antibiotic Pregnant woman woman breastfeed Concurrent active malignancy require immediate therapy Clinically significant cardiac disease ( NY Heart Association Class III IV ) , include chronic arrhythmia , pulmonary disease Known HIV positive status Other serious lifethreatening condition deem unacceptable principal investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>ALL</keyword>
	<keyword>Bone Marrow</keyword>
	<keyword>Ph Negative</keyword>
	<keyword>Daunorubicin</keyword>
	<keyword>Vincristine</keyword>
	<keyword>Prednisone</keyword>
	<keyword>PEG-Asparaginase</keyword>
	<keyword>Methotrexate</keyword>
	<keyword>16-MP ( 6-Mercaptopurine )</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Cytarabine</keyword>
	<keyword>Leucovorin</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>12-266</keyword>
</DOC>